ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "GU Podcast (2020) - Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer"
Episode Synopsis
At the conclusion of this activity, participants will be able to:
1. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients.
2. Explain best practices in MIBC and NMIBC patient selection for various treatment options.
3. Facilitate discussions with patients and caregivers regarding their treatment options.
This educational series is supported by independent educational grants from:
• Astellas
• AstraZeneca
• Bristol Myers Squibb
• Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
• Merck
• Pfizer, Inc
• Sanofi Genzyme
• UroGen Pharma, Inc.
CME Available: auau.auanet.org/node/29836
1. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients.
2. Explain best practices in MIBC and NMIBC patient selection for various treatment options.
3. Facilitate discussions with patients and caregivers regarding their treatment options.
This educational series is supported by independent educational grants from:
• Astellas
• AstraZeneca
• Bristol Myers Squibb
• Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
• Merck
• Pfizer, Inc
• Sanofi Genzyme
• UroGen Pharma, Inc.
CME Available: auau.auanet.org/node/29836
More episodes of the podcast AUAUniversity
Core Curriculum: Anorectal Malformation
22/10/2025
The Latest Breakthroughs in mHSPC
24/09/2025
In God we trust